HCW Biologics’ HCW9218 study published in Journal of Virology
HCW Biologics says a new peer-reviewed study in the Journal of Virology reports promising results for drug candidate HCW9218 in a new indication for HIV treatment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.